DOCSLIB.ORG

The Crucial Vaccine Benefit We're Not Talking About Enough - Scientific American

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Crucial Vaccine Benefit We're Not Talking About Enough - Scientific American 7/30/2021 The Crucial Vaccine Benefit We're Not Talking about Enough - Scientific American P U B L I C H E A L T H The Crucial Vaccine Benefit We’re Not Talking about Enough They not only prevent people from getting sick; they also cut down on transmission by those who get infected after immunization By Daniel P. Oran, Eric Topol on July 27, 2021 Credit: Getty Images COVID vaccines have proved to be magnificent successes, dramatically decreasing the number of cases, hospitalizations and deaths. However, there has been uncertainty about whether vaccinated people who still get infected—perhaps with very mild symptoms, or none at all—might pass on the virus to others. Such silent spread could complicate efforts to control the pandemic. In recent months, there has been a deluge of data on the risk of transmission after vaccination. These findings have important implications for how quickly we can get the pandemic under control, and for what we say to those who are hesitant about getting vaccinated. https://www.scientificamerican.com/article/the-crucial-vaccine-benefit-were-not-talking-about-enough1/?print=true 1/5 7/30/2021 The Crucial Vaccine Benefit We're Not Talking about Enough - Scientific American Vaccine trials are typically designed to determine whether an immunization prevents people from getting sick. These are the efficacy numbers in the headlines—as high as a 95 percent reduction in symptomatic COVID cases for the two FDA-authorized mRNA-based vaccines. But the trials provide little or no data on whether the vaccines can entirely block infection, which is the surest way of minimizing spread of the virus. Considering that at least one third of COVID infections are entirely symptom-free, yet still potentially contagious, it is important to know whether vaccinated people are likely to become carriers of the virus. Not every carrier spreads the virus, though. If a carrier’s viral load is relatively low—meaning that fewer viral particles are shed while breathing and speaking—the risk of transmission is substantially reduced. One possible indirect benefit of a COVID vaccine, then, may be to reduce the viral load in so-called breakthrough cases, or vaccinated people who get infected. Because many health care workers are now routinely tested for COVID, regardless of whether they have symptoms, much of the early real-world data on vaccine effectiveness in blocking infection has come from this population. In several studies of fully vaccinated health care workers—those more than two weeks past their second dose of either mRNA-based vaccine—the likelihood of having a symptomatic or asymptomatic infection was reduced by 80 to 90 percent, compared with those who were unvaccinated. There has been good news, too, on the subject of viral load in breakthrough cases. Researchers in Israel studied vaccinated people who became infected. The viral load in these breakthrough cases was about three to four times lower than the viral load among infected people who were unvaccinated. Researchers in the U.K. reported a similar result. They also found that vaccinated people who became infected tested positive for about one week less than unvaccinated people. We also now have evidence that infected people with lower viral load spread the virus to fewer people, based on contact-tracing studies in the U.S., India and Spain. This is supported by laboratory research demonstrating that nasal samples from infected people with lower viral load are less likely to contain infectious virus. https://www.scientificamerican.com/article/the-crucial-vaccine-benefit-were-not-talking-about-enough1/?print=true 2/5 7/30/2021 The Crucial Vaccine Benefit We're Not Talking about Enough - Scientific American The Delta variant of the coronavirus, now dominant in the U.S. and many other countries, may induce a viral load that is 1,000 times higher than the level that was typically associated with the ancestral lineage of the virus in early 2020. This higher viral load makes Delta infections more contagious, which has led to a greater number of breakthrough cases, albeit many mild or asymptomatic. But the mRNA-based vaccines still provide strong protection, with efficacy against symptomatic infection in the range of 80 to 90 percent. And the ability of these vaccines to substantially reduce viral load in breakthrough cases could be a valuable tool in containing spread of the Delta variant. The totality of these impressive data should bolster confidence that the COVID vaccines are extraordinarily effective in reducing transmission of the virus. This suggests that vaccinating a large majority of Americans throughout the country is our surest bet for returning to normal. Entirely eliminating spread of the virus may be an unreachable goal, but mass vaccination—in the U.S. and around the world—will relegate COVID to the background of our lives. Until now, based on the available data from the vaccine trials, much of the public health messaging around vaccination has focused on the individual benefit. And the efficacy of the COVID vaccines in protecting against illness is indeed remarkable. But with mounting evidence that confirms effectiveness in reducing transmission, it is time to begin emphasizing the societal benefit—and the personal responsibility to avoid harming others. Particularly because so many COVID cases are asymptomatic, an unvaccinated person is at risk of unknowingly becoming a carrier of the virus. Indeed, those who have the lowest risk of severe illness or death from COVID—the young and healthy— are most likely to serve as these unwitting carriers, because they live the most active lives, routinely coming into contact with many others. Sign up for Scientific American’s free newsletters. Sign Up The most important question for those who are hesitant about vaccination, then, is not, “What can the vaccine do for you?” It is, “How many people will you harm if you don’t get vaccinated?” https://www.scientificamerican.com/article/the-crucial-vaccine-benefit-were-not-talking-about-enough1/?print=true 3/5 7/30/2021 The Crucial Vaccine Benefit We're Not Talking about Enough - Scientific American Early in the pandemic, in February 2020, an international business conference in Boston with about 175 attendees became a superspreading event. It has been estimated that, as of November 1, 2020, more than 300,000 infections in the U.S. had been sparked by that conference alone. We are all linked in a vast, invisible network. “Six degrees of separation” is not an exaggeration for the surprising density of our multitudinous interconnections. If you decline vaccination and become infected with the coronavirus, the number of people whom you may inadvertently harm could be astronomical. Mitigation efforts like testing, distancing and masking are imperfect tools for preventing spread of the virus. Vaccination is the closest thing we have to a sure thing in this pandemic. The data are in, and the vaccines are wondrously effective in reducing transmission. The message to those who remain unvaccinated should be: Don’t let the virus use you to harm others. This is an opinion and analysis article; the views expressed by the author or authors are not necessarily those of Scientific American. A D V E R T I S E M E N T A B O U T T H E A U T H O R ( S ) Daniel P. Oran is a member of the digital medicine group at Scripps Research Translational Institute. Eric J. Topol, a professor of molecular medicine at Scripps Research, is founder and director of Scripps Research Translational Institute. Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers. © 2021 SCIENTIFIC AMERICAN, A DIVISION OF SPRINGER NATURE AMERICA, INC. ALL RIGHTS RESERVED. https://www.scientificamerican.com/article/the-crucial-vaccine-benefit-were-not-talking-about-enough1/?print=true 4/5 7/30/2021 The Crucial Vaccine Benefit We're Not Talking about Enough - Scientific American https://www.scientificamerican.com/article/the-crucial-vaccine-benefit-were-not-talking-about-enough1/?print=true 5/5.
Load more

Recommended publications
  • Pattern of Early Human-To-Human Transmission of Wuhan 2019 Novel Coronavirus (2019-Ncov), December 2019 to January 2020
    Rapid communication Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 Julien Riou1 , Christian L. Althaus1 1. Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland Correspondence: Julien Riou ([email protected]) Citation style for this article: Riou Julien , Althaus Christian L. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020;25(4):pii=2000058. https://doi.org/10.2807/1560-7917.ES.2020.25.4.2000058 Article submitted on 24 Jan 2020 / accepted on 30 Jan 2020 / published on 30 Jan 2020 Since December 2019, China has been experiencing Epidemic parameters a large outbreak of a novel coronavirus (2019-nCoV) Two key properties will determine further spread which can cause respiratory disease and severe pneu- of 2019-nCoV. Firstly, the basic reproduction num- monia. We estimated the basic reproduction num- ber R0 describes the average number of secondary ber R0 of 2019-nCoV to be around 2.2 (90% high density cases generated by an infectious index case in a fully interval: 1.4–3.8), indicating the potential for sus- susceptible population, as was the case during the tained human-to-human transmission. Transmission early phase of the outbreak. If R0 is above the critical characteristics appear to be of similar magnitude to threshold of 1, continuous human-to-human transmis- severe acute respiratory syndrome-related coronavi- sion with sustained transmission chains will occur. rus (SARS-CoV) and pandemic influenza, indicating a Secondly, the individual variation in the number of risk of global spread.
    [Show full text]
  • The Sturgis Motorcycle Rally and COVID-19
    DISCUSSION PAPER SERIES IZA DP No. 13670 The Contagion Externality of a Superspreading Event: The Sturgis Motorcycle Rally and COVID-19 Dhaval Dave Andrew I. Friedson Drew McNichols Joseph J. Sabia SEPTEMBER 2020 DISCUSSION PAPER SERIES IZA DP No. 13670 The Contagion Externality of a Superspreading Event: The Sturgis Motorcycle Rally and COVID-19 Dhaval Dave Joseph J. Sabia Bentley University, IZA, NBER and CHEPS CHEPS, San Diego State University and IZA Andrew I. Friedson University of Colorado Denver and CHEPS Drew McNichols CHEPS, University of San Diego-California and San Diego State University SEPTEMBER 2020 Any opinions expressed in this paper are those of the author(s) and not those of IZA. Research published in this series may include views on policy, but IZA takes no institutional policy positions. The IZA research network is committed to the IZA Guiding Principles of Research Integrity. The IZA Institute of Labor Economics is an independent economic research institute that conducts research in labor economics and offers evidence-based policy advice on labor market issues. Supported by the Deutsche Post Foundation, IZA runs the world’s largest network of economists, whose research aims to provide answers to the global labor market challenges of our time. Our key objective is to build bridges between academic research, policymakers and society. IZA Discussion Papers often represent preliminary work and are circulated to encourage discussion. Citation of such a paper should account for its provisional character. A revised version may be available directly from the author. ISSN: 2365-9793 IZA – Institute of Labor Economics Schaumburg-Lippe-Straße 5–9 Phone: +49-228-3894-0 53113 Bonn, Germany Email: [email protected] www.iza.org IZA DP No.
    [Show full text]
  • Mechanistic Transmission Modeling of COVID-19 on the Diamond Princess Cruise Ship Demonstrates the Importance of Aerosol Transmission
    Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission Parham Azimia,1, Zahra Keshavarza, Jose Guillermo Cedeno Laurenta, Brent Stephensb, and Joseph G. Allena,1 aEnvironmental Health Department, Harvard T.H. Chan School of Public Health, Boston, MA 02115; and bDepartment of Civil, Architectural, and Environmental Engineering, Illinois Institute of Technology, Chicago, IL 60616 Edited by Andrea Rinaldo, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, and approved January 7, 2021 (received for review July 22, 2020) Several lines of existing evidence support the possibility of spreads (3). CDC has also acknowledged that airborne trans- airborne transmission of coronavirus disease 2019 (COVID-19). mission by smaller droplets traveling more than 1.8 m away from However, quantitative information on the relative importance of infected individual(s) can sometimes occur (4). transmission pathways of severe acute respiratory syndrome coro- Since the beginning of the pandemic, numerous researchers navirus 2 (SARS-CoV-2) remains limited. To evaluate the relative (5–15) and professional societies [e.g., American Society of Heat- importance of multiple transmission routes for SARS-CoV-2, we ing, Refrigerating and Air-Conditioning Engineers (16)] have raised developed a modeling framework and leveraged detailed informa- concerns that transmission of SARS-CoV-2 can occur from both tion available from the Diamond Princess cruise ship outbreak that symptomatic and asymptomatic (or presymptomatic) individuals to occurred in early 2020. We modeled 21,600 scenarios to generate a others beyond close-range contact through a combination of larger matrix of solutions across a full range of assumptions for eight respiratory droplets that are carried further than 1 to 2 m via air- unknown or uncertain epidemic and mechanistic transmission fac- flow patterns and smaller inhalable aerosols that can remain sus- R2 > tors.
    [Show full text]
  • Overdispersion in COVID-19 Increases the Effectiveness of Limiting Nonrepetitive Contacts for Transmission Control
    Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control Kim Sneppena,1, Bjarke Frost Nielsena, Robert J. Taylorb, and Lone Simonsenb aNiels Bohr Institute, University of Copenhagen, 2100 København Ø, Denmark; and bDepartment of Science and Environment, Roskilde University, 4000 Roskilde, Denmark Edited by Simon Asher Levin, Princeton University, Princeton, NJ, and approved March 8, 2021 (received for review August 5, 2020) Increasing evidence indicates that superspreading plays a domi- generated by an individual is distributed around the mean, with nant role in COVID-19 transmission. Recent estimates suggest that lower values of k corresponding to a broader distribution. the dispersion parameter k for severe acute respiratory syndrome Multiple studies have found that k for SARS-CoV-2 is on the coronavirus 2 (SARS-CoV-2) is on the order of 0.1, which corre- order of 0.1, corresponding to ∼10% of infected people causing sponds to about 10% of cases being the source of 80% of infec- 80% of new infections (12–15) This also implies that the majority tions. To investigate how overdispersion might affect the outcome of infected individuals cause less than one secondary infection of various mitigation strategies, we developed an agent-based and thus, cannot sustain the epidemic on their own should the model with a social network that allows transmission through con- superspreading events somehow be prevented. tact in three sectors: “close” (a small, unchanging group of mutual Consistent with this, the household attack rate is low, as shown “ ” contacts as might be found in a household), regular (a larger, un- by several studies.
    [Show full text]
  • Superspreading of Airborne Pathogens in a Heterogeneous World Julius B
    www.nature.com/scientificreports OPEN Superspreading of airborne pathogens in a heterogeneous world Julius B. Kirkegaard*, Joachim Mathiesen & Kim Sneppen Epidemics are regularly associated with reports of superspreading: single individuals infecting many others. How do we determine if such events are due to people inherently being biological superspreaders or simply due to random chance? We present an analytically solvable model for airborne diseases which reveal the spreading statistics of epidemics in socio-spatial heterogeneous spaces and provide a baseline to which data may be compared. In contrast to classical SIR models, we explicitly model social events where airborne pathogen transmission allows a single individual to infect many simultaneously, a key feature that generates distinctive output statistics. We fnd that diseases that have a short duration of high infectiousness can give extreme statistics such as 20% infecting more than 80%, depending on the socio-spatial heterogeneity. Quantifying this by a distribution over sizes of social gatherings, tracking data of social proximity for university students suggest that this can be a approximated by a power law. Finally, we study mitigation eforts applied to our model. We fnd that the efect of banning large gatherings works equally well for diseases with any duration of infectiousness, but depends strongly on socio-spatial heterogeneity. Te statistics of an on-going epidemic depend on a number of factors. Most directly: How easily is it transmit- ted? And how long are individuals afected and infectious? Scientifc papers and news paper articles alike tend to summarize the intensity of epidemics in a single number, R0 . Tis basic reproduction number is a measure of the average number of individuals an infected patient will successfully transmit the disease to.
    [Show full text]
  • Evidence That Coronavirus Superspreading Is Fat-Tailed BRIEF REPORT Felix Wonga,B,C and James J
    Evidence that coronavirus superspreading is fat-tailed BRIEF REPORT Felix Wonga,b,c and James J. Collinsa,b,c,d,1 aInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139; bDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; cInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142; and dWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115 Edited by Simon A. Levin, Princeton University, Princeton, NJ, and approved September 28, 2020 (received for review September 1, 2020) Superspreaders, infected individuals who result in an outsized CoV and SARS-CoV-2 exhibited an exponential tail. We number of secondary cases, are believed to underlie a significant searched the scientific literature for global accounts of SSEs, in fraction of total SARS-CoV-2 transmission. Here, we combine em- which single cases resulted in numbers of secondary cases pirical observations of SARS-CoV and SARS-CoV-2 transmission and greater than R0, estimated to be ∼3 to 6 for both coronaviruses extreme value statistics to show that the distribution of secondary (1, 7). To broadly sample the right tail, we focused on SSEs cases is consistent with being fat-tailed, implying that large super- resulting in >6 secondary cases, and as data on SSEs are sparse, spreading events are extremal, yet probable, occurrences. We inte- perhaps due in part to a lack of data sharing, we pooled data for grate these results with interaction-based network models of disease SARS-CoV and SARS-CoV-2. Moreover, to avoid higher- transmission and show that superspreading, when it is fat-tailed, order transmission obfuscating the cases generated directly by leads to pronounced transmission by increasing dispersion.
    [Show full text]
  • (COVID-19) Infections from a Family Gathering in Hong Kong
    This is an online COVID-19 pre-publication manuscript which has been submitted to WPSAR. Pre-publication manuscripts are preliminary reports and have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. A superspreading event involving a cluster of 14 coronavirus disease 2019 (COVID-19) infections from a family gathering in Hong Kong LAM Ho Yeung, LAM Tsz Sum, WONG Chi Hong, LAM Wing Hang, LEUNG Chi Mei Emily, LAM Chau Kuen Yonnie, LAU Tin Wai Winnie, HO Chi Hin Billy, WONG Ka Hing, CHUANG Shuk Kwan Abstract Objectives An outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China in December 2019, with subsequent spread around the world. Hong Kong, a Special Administrative Region of China, recorded its first confirmed case on 23 January 2020. In this report, we describe a family cluster of 12 confirmed cases with 2 additional confirmed cases from secondary transmission. Method We reported the epidemiological, clinical and laboratory findings of the family cluster and the public health measures instituted. Results All 12 confirmed COVID-19 cases were among the 19 attendees of a 3-hour Chinese New Year family dinner consisting of hotpot and barbecue. Environmental sampling of the gathering venue was negative. 2 additional confirmed cases who were the co-workers of 2 confirmed cases were later identified, indicating secondary transmission. Contact tracing, quarantine and environmental disinfection were instituted to contain further spread.
    [Show full text]
  • Transmission of SARS-Cov-2: Implications for Infection Prevention Precautions
    Transmission of SARS-CoV-2: implications for infection prevention precautions Scientific brief 9 July 2020 This document is an update to the scientific brief published on 29 March 2020 entitled “Modes of transmission of virus causing COVID-19: implications for infection prevention and control (IPC) precaution recommendations” and includes new scientific evidence available on transmission of SARS-CoV-2, the virus that causes COVID-19. Overview This scientific brief provides an overview of the modes of transmission of SARS-CoV-2, what is known about when infected people transmit the virus, and the implications for infection prevention and control precautions within and outside health facilities. This scientific brief is not a systematic review. Rather, it reflects the consolidation of rapid reviews of publications in peer-reviewed journals and of non-peer-reviewed manuscripts on pre-print servers, undertaken by WHO and partners. Preprint findings should be interpreted with caution in the absence of peer review. This brief is also informed by several discussions via teleconferences with the WHO Health Emergencies Programme ad hoc Experts Advisory Panel for IPC Preparedness, Readiness and Response to COVID-19, the WHO ad hoc COVID-19 IPC Guidance Development Group (COVID-19 IPC GDG), and by review of external experts with relevant technical backgrounds. The overarching aim of the global Strategic Preparedness and Response Plan for COVID-19(1) is to control COVID-19 by suppressing transmission of the virus and preventing associated illness and death. Current evidence suggests that SARS-CoV-2, the virus that causes COVID-19, is predominantly spread from person-to-person.
    [Show full text]
  • Cellular Superspreaders: an Epidemiological Perspective on HIV Infection Inside the Body
    Opinion Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body Kristina Talbert-Slagle1,2*, Katherine E. Atkins1, Koon-Kiu Yan3, Ekta Khurana3, Mark Gerstein3, Elizabeth H. Bradley1,2, David Berg2,4, Alison P. Galvani1, Jeffrey P. Townsend1 1 Yale School of Public Health, New Haven, Connecticut, United States of America, 2 Global Health Leadership Institute, Yale University, New Haven, Connecticut, United States of America, 3 Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, United States of America, 4 Yale University School of Medicine, New Haven, Connecticut, United States of America Introduction CD4+ T cells may play a similarly critical population, there exists a distribution of role in the establishment and spread of individual reproductive numbers, of which Worldwide, more than 250 people HIV in the genital mucosa after sexual R0 is the mean [14]. In populations of become infected with HIV every hour exposure. homogeneous individuals, the distribution [1], yet an individual’s chance of becom- of individual reproductive numbers will be ing infected after a single sexual exposure, Basic and Individual clustered around the population average the predominant mode of HIV transmis- value of R , and thus, this average value Reproductive Number 0 sion, is often lower than one in 100 [2]. will more accurately predict the likelihood When sexually transmitted HIV-1 infec- To quantify the spread of infectious of transmission from each infected to each tion does occur, it is usually initiated by a disease, epidemiologists use the basic susceptible individual. If R0.1, then an single virus, called the founder strain, reproductive number, R , which describes outbreak is likely to become an epidemic, despite the presence of thousands of 0 the average number of secondary infec- and if R0,1, then an outbreak will not genetically diverse viral strains in the tions that arise from one infected individ- spread beyond a few initially infected transmitting partner [3].
    [Show full text]
  • Evidence That Coronavirus Superspreading Is Fat-Tailed
    Evidence that coronavirus superspreading is fat-tailed Felix Wonga,b,c and James J. Collinsa,b,c,d,1 aInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139; bDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; cInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142; and dWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115 Edited by Simon A. Levin, Princeton University, Princeton, NJ, and approved September 28, 2020 (received for review September 1, 2020) Superspreaders, infected individuals who result in an outsized CoV and SARS-CoV-2 exhibited an exponential tail. We number of secondary cases, are believed to underlie a significant searched the scientific literature for global accounts of SSEs, in fraction of total SARS-CoV-2 transmission. Here, we combine em- which single cases resulted in numbers of secondary cases pirical observations of SARS-CoV and SARS-CoV-2 transmission and greater than R0, estimated to be ∼3 to 6 for both coronaviruses extreme value statistics to show that the distribution of secondary (1, 7). To broadly sample the right tail, we focused on SSEs cases is consistent with being fat-tailed, implying that large super- resulting in >6 secondary cases, and as data on SSEs are sparse, spreading events are extremal, yet probable, occurrences. We inte- perhaps due in part to a lack of data sharing, we pooled data for grate these results with interaction-based network models of disease SARS-CoV and SARS-CoV-2. Moreover, to avoid higher- transmission and show that superspreading, when it is fat-tailed, order transmission obfuscating the cases generated directly by leads to pronounced transmission by increasing dispersion.
    [Show full text]
  • 2020.10.21.20216895V1.Full.Pdf
    medRxiv preprint doi: https://doi.org/10.1101/2020.10.21.20216895; this version posted October 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Superspreading Events Without Superspreaders: Using High Attack Rate Events to Estimate No for ​ ​ Airborne Transmission of COVID-19 Mara Prentiss (a), Arthur Chu (b), Karl K. Berggren (c) (a) Department of Physics, Harvard University [email protected]; (b) [email protected];(c) ​ ​ Department of Electrical and Engineering and Computer Science, Massachusetts Institute of Technology; [email protected] Abstract We study transmission of COVID-19 using five well-documented case studies – a Washington state church choir, a Korean call center, a Korean exercise class, and two different Chinese bus trips. In all cases the likely index patients were pre-symptomatic or mildly symptomatic, which is when infective patients are most likely to interact with large groups of people. An estimate of N0, the characteristic ​ ​ ​ number of COVID-19 virions needed to induce infection in each case, is found using a simple physical model of airborne transmission. We find that the N0 values are similar for five COVID-19 superspreading ​ ​ ​ cases (~300-2,000 viral copies) and of the same order as influenza A. Consistent with the recent results of Goyal et al, these results suggest that viral loads relevant to infection from presymptomatic or mildly ​ ​ symptomatic individuals may fall into a narrow range, and that exceptionally high viral loads are not required to induce a superspreading event [1,2].
    [Show full text]
  • Using Network Visualization to Understand the Spread of Covid-19, by Tod Van Gunten
    Using network visualization to understand the spread of Covid-19, by Tod Van Gunten Like many infectious diseases, COVID-19 spreads most often through direct social contact. We are most likely to catch the virus through sustained social interaction: because of this, following a ‘15 minute rule,’ contact tracers seek to identify individuals who infected persons have interacted with for a period of 15 minutes or more at a distance of under two metres. These interactions are most likely to happen with friends, family, co-workers and others with whom we share regular social relationships. In other words, the virus that causes Covid-19 tends to spread through our social networks. Because of this, epidemiologists have long studied the properties of social networks and how they affect disease spread. Sexually transmitted diseases such as HIV/AIDS are an important example: because STDs spread through sexual contact, patterns of sexual interactions and the underlying social relations shape how a disease spreads in a population. Although SARS-CoV-2 (the virus that causes COVID-19) can spread through less intimate relationships, the same principle applies. An important property of social networks is the variability between individuals in the number of such relationships (network analysts call this the degree distribution). This property may help explain how viral diseases spread. Individuals who interact with many people could spread a virus to more others than those who interact with fewer. Epidemiologists emphasize that the now infamous ‘r’ number, the number of infections resulting from a single prior infection, is also varies widely. Most COVID-19 infections result from a small number of previously infected individuals: in a study of the pandemic in Hong Kong, 80% of cases resulted from around 20% of previously infected individuals.
    [Show full text]